Form 4: Director Jennifer Johnson Acquires Thermo Fisher Shares

Thermo Fisher Scientific director Jennifer M. Johnson acquired 499 shares of common stock as part of a routine equity grant.

Summary

• Director Jennifer M. Johnson acquired 499 shares of Thermo Fisher Scientific Inc. (TMO) common stock.
• The transaction occurred on May 20, 2026.
• The shares were acquired at a price of $0, indicating an equity compensation grant.
• Following this transaction, the reporting person holds 1,403 shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• Director alignment with shareholder interests through increased equity ownership.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine disclosure of director equity compensation.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to align board member incentives with long-term shareholder value in the life sciences and diagnostics sector.

Comparison to Industry Standards

• The acquisition follows standard industry practices for compensating independent directors with equity in large-cap S&P 500 companies.

Related Party Transactions

• The reporting person is the CEO of Franklin Resources, Inc., which manages investment products that hold shares of the issuer; the reporting person disclaims beneficial ownership of those shares.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity grant.

Next Steps

• None identified.

Key Dates

Keywords

Thermo Fisher Scientific, TMO, Form 4, Insider Trading, Director Acquisition, Equity Compensation